Stereotaxis (STXS) Cash from Operations Growth (3y) (2013 - 2026)
Stereotaxis (STXS) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.79 Bn | 121.57 Bn | 1.96 Bn | 16.81% |
| 2 | Becton Dickinson | 45.00 Bn | 44.18 Bn | 2.15 Bn | 53.64% |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | 70.05% |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.50 Bn | 27.84 Bn | 890.98 Mn | 25.17% |
| 6 | West Pharmaceutical Services | 23.14 Bn | 22.71 Bn | 329.20 Mn | -9.84% |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | -33.35% |
| 8 | Cooper Companies | 13.88 Bn | 13.74 Bn | 735.40 Mn | 13.75% |
| 9 | Align Technology | 12.15 Bn | 11.09 Bn | 736.59 Mn | -8.92% |
| 10 | Stereotaxis | 134.49 Mn | 119.88 Mn | 3.79 Mn | -7.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.10% |
| Dec 31, 2025 | -15.86% |
| Sep 30, 2025 | -18.40% |
| Jun 30, 2025 | -48.63% |
| Mar 31, 2025 | 6.74% |
| Dec 31, 2024 | 44.84% |
| Sep 30, 2024 | -43.79% |
| Jun 30, 2024 | -352.78% |
| Mar 31, 2024 | -97.40% |
| Dec 31, 2023 | -114.87% |
| Sep 30, 2023 | -26.04% |
| Jun 30, 2023 | -35.78% |
| Mar 31, 2023 | -8.96% |
| Dec 31, 2022 | -10.05% |
| Sep 30, 2022 | -84.12% |
| Jun 30, 2022 | -29.88% |
| Mar 31, 2022 | -7.26% |
| Dec 31, 2021 | -16.19% |
| Sep 30, 2021 | -82.80% |
| Jun 30, 2021 | -58.91% |